Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia

Background: Typically, closed-loop control (CLC) studies excluded patients with significant hypoglycemia. We evaluated the effectiveness of hybrid CLC (HCLC) versus sensor-augmented pump (SAP) in reducing hypoglycemia in this high-risk population. Methods: Forty-four subjects with type 1 diabetes, 2...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Diabetes Technol Ther
Päätekijät: Anderson, Stacey M., Buckingham, Bruce A., Breton, Marc D., Robic, Jessica L., Barnett, Charlotte L., Wakeman, Christian A., Oliveri, Mary C., Brown, Sue A., Ly, Trang T., Clinton, Paula K., Hsu, Liana J., Kingman, Ryan S., Norlander, Lisa M., Loebner, Sarah E., Reuschel-DiVirglio, Suzette, Kovatchev, Boris P.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Mary Ann Liebert, Inc., publishers 2019
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6551970/
https://ncbi.nlm.nih.gov/pubmed/31095423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2019.0018
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia